On April 19, 2023, the Centers for Disease Control and Prevention (CDC) amended the emergency use authorizations (EUA) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines. Refer to this fact sheet, from provided by TMF Quality Innovation Network, for the latest recommendations.
